Genzyme Feels the Heat
451993
Drug company faces first true competition to its enzyme replacement therapy for Gaucher disease.
317406
In an unusual hostile takeover attempt, Genzyme Corp. yesterday went public with a $380 million cash offer to buy a Canadian drug-development company whose board of directors has twice rejected the bid.
485103
Genzyme Corp.  said on Friday its experimental drug tolevamer, a treatment for diarrhea associated with the intestinal infection Clostridium difficile, worked no better than a standard antibiotic, sending the company's shares down more than 5 percent in early trading.
727152
New developments are brewing at the pharmaceutical.
189338
Genzyme buys a piece of Isis' mipomersen at a wowser of a price.
549383
THE REGION Genzyme Corp. , maker of enzyme therapies for rare diseases, had a loss in the fourth quarter on acquisition costs but expects higher sales in 2007. The net loss was $268.2 million, or $1.02 a share, versus net income of $106.6 million, or 39 cents, a year earlier, the Cambridge company said. Profit excluding some costs beat analyst ...
17876
Gene therapies could one day offer relief from allergies such as hayfever, claim UK and Swiss scientists.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
640929
Shares of Cambridge-based Genzyme were up slightly today on news that the drug maker won approval for a drug to treat childhood leukemia.
551267
American scientists have claimed that an enzyme present in almost all animal and human cells can be used for the treatment of inflammatory diseases.
171744
New drugs that are to be tested in connection with a phenomenon called RNA interference have excited scientists with their versatile and powerful ability to affect genes.
18221
Genzyme has agreed to pay at least $325 million to win the hotly contested rights to a potentially powerful cholesterol-lowering drug.
442213
THURSDAY, Sept. 21 (HealthDay News) -- Some bad news has emerged from a study of an enzyme that is a major target in the effort to find new drugs to fight Alzheimer's disease.
488705
A new gene therapy causes the bladder to act like a &quot;bioreactor&quot; and secrete an anticancer agent that has proven to fight human tumors.
134636
By harnessing a natural gene-silencing mechanism, scientists say they have dramatically reduced the activity of a protein linked to high cholesterol.
74167
Nanoparticles allow researchers to initiate biochemical events at will.
447460
Biotechnology company Genzyme Corp   reported a fourth-quarter profit on Wednesday,  reversing a year-earlier loss, as sales of its drugs for rare  diseases increased.